These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5556066)

  • 1. Management of abnormal bleeding.
    Cope E
    Br Med J; 1971 Jun; 2(5763):700-1. PubMed ID: 5556066
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of menorrhagia.
    Nilsson L; Rybo G
    Am J Obstet Gynecol; 1971 Jul; 110(5):713-20. PubMed ID: 5563236
    [No Abstract]   [Full Text] [Related]  

  • 4. ORAL CONTRACEPTIVES AND LIVER DAMAGE.
    STOLL BA; ANDREWS JT; MOTTERAM R; UPFILL J
    Br Med J; 1965 Mar; 1(5436):723. PubMed ID: 14245215
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal uterine bleeding in the perimenopause.
    Awwad JT; Toth TL; Schiff I
    Int J Fertil Menopausal Stud; 1993; 38(5):261-9. PubMed ID: 8298664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraceptives in the treatment of the meno-metrorrhagia of the solitary ovary syndrome after unilateral castration].
    Vasiliu V; Filipescu D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):Suppl:485-6. PubMed ID: 5759285
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the use of estroprogestinics in the control of lactation].
    Malato M
    Arch Ostet Ginecol; 1969; 74(5):381-9. PubMed ID: 5408023
    [No Abstract]   [Full Text] [Related]  

  • 8. CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES.
    MEARS E
    Proc R Soc Med; 1964 Mar; 57(3):204-7. PubMed ID: 14130873
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-Ovlon-Use in contraception and treatment of gynaecological affections(author's transl)].
    Dvorák K
    Cesk Gynekol; 1974 Nov; 39(9):716-8. PubMed ID: 4615825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial use of Sophia-32].
    Kanazawa Y
    Horumon To Rinsho; 1969 Jul; 17(7):611-4. PubMed ID: 5390067
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysfunctional uterine bleeding.
    Boyd ME
    Can J Surg; 1986 Sep; 29(5):305-7. PubMed ID: 3019496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional uterine bleeding: diagnosis and treatment.
    Strickler RC
    Postgrad Med; 1979 Nov; 66(5):135-42, 145-6. PubMed ID: 493183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION.
    JACKSON MC; LINN R
    Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Proctor DD; Henderson KJ; Dziura JD; White RI
    J Clin Gastroenterol; 2008 Jul; 42(6):756-7. PubMed ID: 18496387
    [No Abstract]   [Full Text] [Related]  

  • 15. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 16. OVULATION INHIBITION BY PROGESTIN-ESTROGEN COMBINATION.
    GARCIA CR; PINCUS G
    Int J Fertil; 1964; 9():95-105. PubMed ID: 14106273
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysfunctional uterine bleeding in women over 40 years of age.
    Ngu A; Quinn MA
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):30-3. PubMed ID: 6588959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50.
    Otolorin EO; Falase EA; Ladipo OA
    Afr J Med Med Sci; 1990 Mar; 19(1):15-22. PubMed ID: 2109515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE INHIBITION OF OVULATION WITH ORAL PROGESTATIVE SUBSTANCES.
    KAISER R
    Int J Fertil; 1964; 9():87-93. PubMed ID: 14106272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.